University of Chicago Comprehensive Cancer Center: Innovation in Research

Laura Bruck
Published: Friday, Jul 06, 2012
University of Chicago Comprehensive Cancer Center

University of Chicago Comprehensive Cancer Center

For nearly 40 years, the University of Chicago (UChicago) Comprehensive Cancer Center (UCCCC) has enjoyed a reputation for excellence and innovation, with more than 200 basic and physician scientists collaborating on research aimed at transforming cancer prevention, screening, and treatment. UCCCC researchers have pioneered studies in a broad range of areas, including the molecular genetics of cancer, cancer immunology, bone marrow transplantation, hormone therapy, and advanced imaging techniques.

Genomic Prescribing: The 1200 Patients Project Initiated at UChicago, and the flagship project of the newly created Center for Personalized Therapeutics directed by Mark J. Ratain, MD, the 1200 Patients Project is examining the feasibility and potential benefits of using a patient’s genetic information to guide pharmacologic treatment decisions and develop personalized therapeutics throughout his or her lifetime. The study was initiated in January 2011 and by April 2012 had enrolled more than 700 of an anticipated 1200 UChicago outpatients.

Dr. Peter H. O’Donnell

Peter H. O’Donnell, MD

Upon enrollment in this first-of-its-kind, 3-year study, each patient submits a single blood sample that is tested for all published genetic markers that might predict response to hundreds of drugs, as well as the likelihood of adverse effects. Patient-specific results will then be made available to study-participating physicians, who will be monitored to determine whether they use the information in decisions about medicine selection or dosing, O’Donnell explained.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions
 
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2019
Intellisphere, LLC. All Rights Reserved.
 
x